MARIMED INC (OTCMKTS:MRMD) on Focus After Report of Less Shorts

The stock of MARIMED INC (OTCMKTS:MRMD) registered a decrease of 14.36% in short interest. MRMD’s total short interest was 728,200 shares in March as published by FINRA. Its down 14.36% from 850,300 shares, reported previously. With 713,600 shares average volume, it will take short sellers 1 days to cover their MRMD’s short positions.

The stock decreased 0.48% or $0.018 during the last trading session, reaching $3.712. About 209,236 shares traded. MariMed Inc. (OTCMKTS:MRMD) has 0.00% since March 17, 2018 and is . It has underperformed by 4.37% the S&P500.

MariMed Advisors, Inc. provides consulting services for the design, development, operation, funding, and optimization of medical cannabis cultivation centers and dispensaries. The company has market cap of $791.82 million. The firm offers dispensary and cultivation application assistance, real estate suitability and safe access, initial build-out and ongoing consultation, business acceleration solutions, and physician and patient outreach services. It currently has negative earnings. It serves clients in Florida, Illinois, Maryland, Minnesota, and Nevada.

More notable recent MariMed Inc. (OTCMKTS:MRMD) news were published by: Profitconfidential.com which released: “Step-by-Step Guide on How to Invest in Marijuana Stocks – Profit Confidential” on December 10, 2018, also Investorplace.com with their article: “10 Top Pot Stocks 2019 Has to Offer – Investorplace.com” published on March 08, 2019, Profitconfidential.com published: “Investing in Pot: Are Marijuana Stocks a Safe Investment? – Profit Confidential” on December 05, 2018. More interesting news about MariMed Inc. (OTCMKTS:MRMD) were released by: Investorplace.com and their article: “7 U.S. Marijuana Stocks to Buy for the Midterm Elections – Investorplace.com” published on October 31, 2018 as well as Investorplace.com‘s news article titled: “The 7 Best Stocks to Buy Now That Jeff Sessions Is Gone – Investorplace.com” with publication date: November 08, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.